Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Gene Medicine : A New Field of Molecular Medicine

  • Kim, Chong-Kook (National Research Laboratory for Drug and Gene Delivery, College of Pharmacy, Seoul National University) ;
  • Haider, Kh-H (National Research Laboratory for Drug and Gene Delivery, College of Pharmacy, Seoul National University) ;
  • Lim, Soo-Jeong (National Research Laboratory for Drug and Gene Delivery, College of Pharmacy, Seoul National University)
  • Published : 2001.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Gene therapy has emerged as a new concept of therapeutic strategies to treat diseases which do not respond to the conventional therapies. The principle of gene therapy is to Introduce genetic materials into patient cells to produce therapeutic proteins in these cells. Gene therapy is now at the stage where a number of clinical trials have been carried out to patients with gene-deficiency disease or cancer. Genetic materials for gene therapy are generally composed of gene expression system and gene delivery system. For the clinical application of gene therapy in a way which conventional drugs are used, researches have been focused on the design of gene delivery system which can offer high transfection efficiency with minimal toxicity. Currently, viral delivery systems generally provide higher transfection efficiency compared with non-viral delivery systems while non-viral delivery systems are less toxic, less immunogenic and manufacturable in large scale compared with viral systems. Recently, novel strategies towards the design of new non-viral delivery system, combination of viral and non-viral delivery systems and targeted delivery system have been extensively studied. The continued effort in this area will lead us to develop gene medicine as "gene as a drug" in the near future.

Keywords

References

  1. Am. J. Pathol. v.156 no.4 Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells:A gene therapy approach Albini,A.;Marchisone,C.;Del Grosso, E.;Benelli,R.;Masiello,L.;Taochetti,C.;Bono,M.;Ferrantini,M.;Rozera,C.;Truini,M.;Belardelli,F.;Santi,L.;Noonan,D.M.
  2. Clin Exp. Pharmacol. Physiol. v.26 Gene transfer and models of gene therapy for the myocardium Alexander,M.Y.;Webster,K.A.;McDonald,P.H.;Prentice,H.M.
  3. J. Mol. Med. v.75 no.4 Specific cytotoxic T lymphocytes in gene therapy Altenschmidt,U.;Moritz,D.;Groner,B.
  4. Human Gene Ther. v.1 The ADA human gene therapy clinical protocol Anderson,W.F.;Blease,R.M.;Kulver,K.
  5. Science v.288 no.5466 Gene therapy:the best of times and the worst of times Anderson,W.E.
  6. Nature v.392 Human gene therapy Anderson,W.E
  7. Adv. Drug Deliv. Rev. v.38 Biological barriers to cellular delivery of lipid based DNA carriers Bally,M.B.;Harvie,P.;Wong,F.M.;P.Kong;Wasan,E.K.;Reimer,D.L.
  8. Gene Ther. v.6 Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes Barron,L.G.;Uyechi,L.S.;Szoka,Jr.
  9. Int. J. Pharm. v.181 Targetability of novel immunoliposomes prepared by a new antibody conjugation technique Bendas,G.;Krause,A.;Bakowsky,U.;Vogel,J.;Rothe,U.
  10. J. Pharm. Sci. v.82 no.11 Submicron emulsions as colloidal drug carriers for intravenous administration:comprehensive physicochemical characterization Benita,S.;Levy,M.Y.
  11. Bioconjug, Chem. v.18;11 no.5 pH-sensitive cationic polymer gene delivery vehicle:N-Ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer Benns,J.M.;Choi,J.S.;Mahato,R.I.;Park,J.S.;Kim,S.W.
  12. Baillieres Clin Haematol. v.11 no.1 Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesis Blau,C.A.
  13. Nat. Med. v.6 no.6 Gene therapy for human SCID:dreams become reality Buckley,R.H.
  14. Nat. Med. v.1 Liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis Caplen,N.J.;Alton,E.W.F.W.;Middleton,P.G.;Dorin,J.R.;Stevenson,B.J.;Gao,X.;Durham,S.R.;Jefferey,P.K.;Hodson,M.E.;Coutelle,C.;Huang,L.;Proteous,S.J.;Williamson,R.;Geddes,D.M.
  15. Biotecnology(2nd Ed.) v.5a Viral vectors for gene theraphy Carter,B.J.;Mountain,A.(et al.)
  16. Transfus. Clin. Biol. v.7 no.3 Gene therapy of severe combined immunodeficiencies Cavazzana-Calvo, M.;Hacein-Bey, S.;de Saint-Basile, G.;Le Deist, E.;Fischer,S.
  17. Hum. Gene. Ther. v.11 no.6 Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor Chang,A.E.;Li,Q.;Bishop,D.K.;Normolle,D.P.;Redman,B.D.;Nickoloff,B.J.
  18. Related Articles Cherng
  19. Pharm. Res. v.6 no.9 Long term stability of poly((2-dimethylamino)ethyl methacrylate)-based gene delivery systems Cherng,J.Y.;Talsma,H.;Crommelin,D.J.;Hennink,W.E.
  20. Gene Ther. v.6 Immune responses to adenoviruses and adenoassociated virusesin humans Chirmule,N.
  21. J. Control. v.Release 54 Choi,Y.H.
  22. Surg Oncol Clin N Am. v.7 no.3 Gene therapy for tumors of the central nervous system Chung,R.Y.;Chiocca,E.A.
  23. Mol. Med. Today v.6 Gene therapy strategies for colon cancer Chung-Faye,G.A.;Kerr,D.J.;Young,L.S.;Searle,P.F.
  24. Gene Ther. v.7 Regulated gene expression systems Clackson,T.
  25. Proc. Natl. Acad. Sci. USA v.96 Transient and stable gene expression in mammalian cells transduced with recombinant baculovirus Condreay,J.P.;Witherspoon,S.M.;Clay,W.C.;Kost,T.A.
  26. Human Gene Ther. v.10 Gene transfer to the nigrostriatl system by hybrid herpes simplex virus/AAV amplicon vectors Costantini,L.C.;Jacoby,D.R.;Wang,S.;Fraefel,C.;Break-field,X.O.;Isacson,O,
  27. Cancer Gene Ther. v.3 Epidermal growth factor mediated DNA delivery in to lung cancer cells via the epidermal growth factor receptor Cristiano,R.J.;Roth,J.A.
  28. Am. J. Res. Cell. Biol. v.14 Gene therapy approaches for inherited and acquired lung diseases Cruiel,D.T.;Pilewski,J.M.;Albelda,S.M.
  29. Am. J. Respir. Cell Mol. Biol. v.14 no.1 Gene therapy approaches for inherited and acquired lung diseases Curiel,D.T.;Pllewski,J.M.;Albelda,S.M.
  30. J. Pharm. Pharmacol. v.49 no.10 Enhanced anticancer therapy mediated by specialized liposomes Dass,C.R.;Walker,T.L.;Burton,M.A.;Decruz,E.E.
  31. J. Mol. Med. v.77 Efficient gene delivery in to cardio-myocytes by recombinant Sindibis virus Datwyler,D.A.;Eppenberger,H.M.;Koller,D.;Bailey,J.E.;Magyar,J.P.
  32. Blood v.95 no.2 Glass needle mediated microinjection of macro-molecules and trangenes in to primary human blood cell/ progenitor cells Davis,B.R.;Brown,J.Y.;Prokopishyn,N.L.;Luo,Z.;Smith,M.R.;Wang,J.;Carsurd,N.D.V.;Brown,D.B.
  33. Crit. Rev. Thera. Drugs Carrier Sys. v.17 no.2 Cationic polymer based gene delivery systems De Smedt,S.C.;Demeester,J.;Hennik,W.E.
  34. Biochimica Biophysica Acta v.1332 Gene therapy:meeting report Dranoff,G.
  35. Biochim Biophys Acta v.1325 no.1 Biophysical characterization of cationic lipid:DNA complexes Eastman,S.J.;Siegel,C.;Tousignant,J.;Smith,A.E.;Cheng,S.H.;Scheule,R.K.
  36. Int. J. Pharmaceutics v.189 Preparation and characterization of cationinc microspheres for gene delivery Esposito,E.;Sobben,S.;Cortesi,R.;Menegatti,E.;Nastruzzi,C.
  37. J. Biol. Chem. v.269 no.4 Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations Felgner,J.H.;Kumar,R.;Sridhar,C.N.;Wheeler,C.J.;Tsai,Y.J.;Border,R.;Ramsey,P.;Martin,M.;Felgner,P.L.
  38. Sci. Am. v.276 Non-viral strategies for gene therapy Feigner,P.
  39. Human Gene Ther. v.8 Nomencultuire of synthetic gene therapy Felgner,P.I.;Barenholz,Y.;Behr,J.P.;Cheng,S.H.;Cullis,P.;Huang,L.;Jessee,J.A.;Seymour,L.;Szoka,E.;Thierry,A.R.;Wagner,E.;Wu,G.
  40. J. Immunol. v.158 Different T-helper cell types and antibody isotypes generated by saline and gene gun immunization Feltquate,D.M.;HeaNEY S.;Webster,R.G.;Robinson,H.L.
  41. Biochim Biophys Acta v.1447 no.2-3 Polyethylenimine shows properties of interest for cystic fibrosis gene therapy Ferrari,S.;Pettenazzo,A.;Garbati,N.;Zacchello,F.;Behr,J.P.;Scarpa,M.
  42. Kidney Int. v.49 Progress in human gene therapy Feuerbach,F.J.;Crystal,R.G.
  43. Gene Ther. v.7 no.14 Protective copolymers for nonviral gene vectors:synthesis, vector characterization and application in gene delivery Finsinger,D.;Remy,J.S.;Erbacher,P.;Koch,C.;Plank,C.
  44. Gene Ther. no.3 Reversing liver cirrhosis:impact of gene therapy for liver cirrhosis Fujimoto,J.;Kaneda,Y.
  45. Proc. Natl. Acad. Sci. USA v.90 DNA vaccines:protective immunization by parenteral, mucosal and gene gun inocculations Fynan,E.F.;Webster,R.G.;Fuller,D.H.;Haynes,J.R.;Santoro,J.C.;Robinson,H.L.
  46. Int. J. Pharm. v.161 Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A Gao,Z.G.;Choi,H.G.;Sinn,H.J.;Park,K.M.;Lim,S.J.;Hwang,K.J.;Kim,C.K.
  47. Crit. Rev. Thera. Drugs Carrier Sys. v.16 no.2 Gene delivery systems using cationinc polumers Garnett,M.C.
  48. Monaldi Arch. Chest. Dis. v.50 no.5 Gene therapy for alpha 1-antitrypsin deficiency Geddes,D.M.;Beckles,M.A.
  49. Mol. Therapy v.2 no.2 Efficient nonviral cutaneous transfection Glasspool-Malone,J.;Somiari,S.;Drabick,J.;Malone,R.W.
  50. Proc. Natl. Acad. Sci. USA v.95 no.11 Reversal of tolerance to human MUCI antigen in MUCI transgenic mice immunized with fusions of dendritic and carcinoma cells Gong,J.;Chen,D.;Kashiwaba,M.;Li,Y.;Chen,L.;Takeuchi,H.;Qu,H.;Rowse,G.J.;Gendler,S.J.;Kute,D.
  51. Hum. Gene Ther. v.3 no.5 Transplantation of genetically modified autologous hepatocytes into nonhuman primates:feasibility and short-term toxicity Grossman,M.;Raper,S.E.;Wilson,J.M.
  52. Mol. Medicine Today v.6 Gene therapy strategies for colon cancer Guy,A.C.E.;David,J.K.;Lawrence,S.Y.;Peter,F.S.
  53. Mol. Med. Today v.6 no.6 New approaches to treating haemophilia Habeck,M.
  54. Adv. Drug. Deliv. Res. v.24 Emusion formulations as a vector for gene delivery in vivo and in vitro Hara,T.;Liu,F.;Liu,D.;Huang,L.
  55. Expert Opin. Ther. Patents v.10 no.2 Synthetic vactors for gene therapy Hart,S.L.
  56. J. Immunol. Methods v.229 no.1-2 Nucleic acid immunization:concepts and techniques assoicated with third generation vaccines Hasan,U.A.;Abai,A.M.;Harper,D.R.;Wren,B.W.;Morrow,W.J.
  57. Somatic gene therapy Direct gene transfer in vivo Herweijer,H.;Fritz,J.D.;Hagstorm,J.E.;Wolff,J.A.;Chang,P.L.(ed.)
  58. J. Virol. v.74 no.10 Design and packaging of adenoassociated virus gene targeting vectors Hirata,R.K.;Russell,D.W.
  59. Human Gene Ther. v.11 no.6 Photo-chemical transfection:a new technology for light induced site directed gene delivery Hogset,A.;Prasmickaita,L.;Tjelle,T.E.;Berg,K.
  60. Human Gene Ther. v.5 Delivery of secretable adenosine deaminase through microcapsules-a novel approach to somatic gene therapy Hughes,M.;Vassilakos,A.;Andrews,D.W.;Hortelano,G.;Belmont,J.W.;Chang,P.L.
  61. Adv. Drug Deliv. Rev. v.35 In vivo gene delivery by electroporation Jaroszeski,M.J.;Gilbert,R.;Nicolau,C.;Heller,R.
  62. P.S.T.T. v.2 no.9 Taking polycation gene delivery systems from in vitro to in vivo Kabanov,A.
  63. Adv. Drug Deliv. Rev. v.30 no.1-3 Interpolyelectrolyte and block ionomer complexes for gene delivery:physico-chemical aspects Kabanov,V.A.;Kabanov,A.V.
  64. Mol. Med. Today v.5 Gene therapy using HVJ-liposomes:the best of both the worlds? Kaneda,Y.;Saeki,Y.;Morishita,R.
  65. Proc. Natl. Acad. Sci. USA v.83 no.17 Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer Kantoff,P.W.;Kohn,D.B.;Mitsuya,H.;Armentano,D.;Sieberg,M.;Zwiebel,J.A.;Eglitis,M.A.;McLachlin,J.R.;Wiginton,D.A.;Hutton,J.J.(et al.)
  66. Israel Med. Assoc. J. v.2 no.1 Gene therapy:the ball takes a spin towards multifactorial diseases Karin,N.
  67. Pharm. Res. v.17 no.3 vivo gene delivery to the liver using novel galactosylated cationic liposmes Kawakami,S.;Fumoto,S.;Makiya,N.;Yamashita,F.;Hashida,N.
  68. Int. J. Pharm. v.180 Pharmacodynamics of insulin in polyethylene glyol-coated liposomes Kim,A.;Yun,M.O.;Oh,Y.K.;Ahn,W.S.;Kim,C.K.
  69. Int. J. Pharm. v.147 Enhanced lymph node delivery and immunogenecity of hepatitis B surface antigen entrapped in galactosylated liposomes Kim,C.K.;Jeong,E.J.
  70. Int. J. Pharm. v.101 Development of the glucose-triggered pH-sensitive liposome for a potential insulin delivery Kim,C.K.;Im,E.B.;Lim,S.J.;Oh,Y.K.;Han,S.K.
  71. J. Microencap. v.17 no.3 Comparison of in vivo fate and immunogenecity of hepatitis B surface antigen incorporated in cationic neutral liposomes Kim,C.K.;Jeong,E.J.;Kim,M.H.
  72. Mol. Cell. v.10 no.2 vivo gene transfer to the mouse nasal cavity mucosa using a stable cationic lipid emulsion Kim,T.W.;Chung,H.;Kwon,I.C.;Sung,H.C.;Jeong,S.Y.
  73. J. Gene Med. v.1 Direct immunologic activities of CpG DNA and implications for gene therapy Kreigh,A.M.
  74. Histol Histopathol. v.15 no.4 Gene therapy using herpes simplex virus-based vectors Latchman,D.S.
  75. FEBS Lett. v.443 no.1 Uptake by rat liver and intracellular fate of plasmid DNA complexed with poly-L-lysine or poly-D-lysine Laurent,N.;Wattiaux-De Coninck, S.;Mihaylova,E.;Leontieva,E.;Warnier-Pirotte,M.T.;Wattiaux,R.;Jadot,M.
  76. Human Gene Ther. v.6 Non viral gene therapy:the promise of genes as aparmaceutical product Ledley,F.D.
  77. Pharm. Res. v.13 no.11 Pharmaceutical approach to somatic gene therapy Ledley,F.D.
  78. Human Gene Ther. v.7 Detailed analysis of structures and formulations of cationic lipids for efficient gene trasfer to the lungs Lee,E.R.;Marshall,J.;Siegel,C.S.;Jiang,C.;Yew,N.S.;Nichols,M.R.;Nietupski,J.B.;Zeigler,R.J.;Lane,M.B.;Wang,X.;Wan,N.C.;Harris,D.J.;Smith,A.E.;Cheng,S.H.
  79. Int. J. Pharm. v.191 Pharmacokinetis and organ distribution of cyclosporin A incorporated in liposome and mixed micelle Lee,M.K.;Choi,L.;Kim,M.H.;Kim,C.K.
  80. Crit. Rev. Ther. Drug Carrier Sys. v.14 no.2 Lipid vector systems for gene transfer Lee,R.J.;Huang,L.
  81. Vaccines v.18 DNA and RNA based vaccines:principles, progress and prospects Leitner,W.W.;Ying,H.;Restifo,N.P.
  82. Gene Ther. v.7 Non-viral gene therapy:promises and challenges Li,S.;Huang,L.
  83. Bioconjug. Chem. v.11 no.5 Poly(DMAEMA-NVP)-b-PEG-galactose as gene delivery vector for hepatocytes Lim,D.W.;Yeom,Y.I.;Park,T.G.
  84. Pharm. Res. v.17 no.7 Biodegradable polyester, poly (alph-(4-aminobutyl)-L-glycolic aicd), as a non-toxic gene carrier Lim,Y.B.;Han,S.O.;Kong,H.U.;Lee,Y.;Park,J.S.;Jeong,B.;Kim,S.W.
  85. Int. J. Dermatol. v.39 The gene gun:current applications in cutaneous gene therapy Lin,M.T.S.;Pulkinen,L.;Uitto,J.;Yoon,K.
  86. Gene Ther. v.6 Hydrodynamics based transfection in animals by systemic administration of plasmid DNA Liu,F.;Song,Y.;Liu,D.
  87. Pharm. Res. v.13 no.12 New cationic lipid formulations for gene transfer Liu,F.;Yang,J.;Huang,L.;Liu,D.
  88. Nat. Biotech. v.18 no.1 Synthetic DNA delivery system Luo,D.;Saltzman,W.M.
  89. Adv. Genetics v.41 Pharmaceutical perspective of nonviral gene therapy Mahato,R.I.;Smith,L.C.;Rolland,A.
  90. Mol. Therapy v.2 no.2 Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment Maheshwari,A.;Mahato,R.I.;McGregor,J.;Han,S.;Samlowski,W.E.;Park,J.S.;Kim,S.W.
  91. Adv. Drug Deliv. Rev. v.41 Gene transfer for human endothelial cells Martin,S.G.;Murray,J.C.
  92. Adv. Drug Deliv. Rev. v.40 Immunoliposomes for targeted delivery of antitumour drugs Mastrobatista,E.;Koning,G.A.;Storm,G.
  93. Vaccine v.15 no.4 Hepatitis B vaccine administration:comparison between jet-gun and syringe and needle Mathei,C.;Van Damme, P.;Meheus,A.
  94. Gene Ther. v.6 no.9 Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres Matthews,C.;Jenkuns,G.;hilfinger,J.;Davidson,B.
  95. Mol. Membrane Biol. v.16 Lipid based systems for intracellular delivery of genetic drugs Maurer,N.;Mori,A.;Palmer,L.;Monck,M.A.;Mok,K.W.C.;Mui,B.;Akhong,Q.E.;Cullis,P.R.
  96. J. Bone Mine. Res. v.14 Adenovirus mediated gene therapy of osteoblasts in vitro and in vivo Mehrara,B.J.;Saadeh,P.B.;Steinbrech,D.S.;Dudziak,M.;Spector,J.A.;Greenwald,J.A.;Gittes,G.K.;Longarker,M.T.
  97. Endocrinol. Rev. v.18 Glucose stimulated genes and prospects for gene therapy for type-1 diabetes Mitanchez,D.;Doiron,B.;Chen,R.;Kahn,A.
  98. Pro. Natl. Acad. Sci. USA v.94 Stable and efficient gene transfer in to the retina using HIV-based lentiviral vector Miyoshi,H.;Takahashi,M.;Gage,F.H.;Verma,I.M.
  99. J. Virol. v.72 High titers HIV type-1 based vactor systems for gene delivery in to non-dividing cells Mochizuki,H.;Schwartz,J.P.;Tanak,K.;Brady,R.O.;Reiser,J.
  100. Gene Ther. v.5 Efficient transgene regulation from a single tetracycline controlled positive feedback regulatory system Mohammdi,S.;Hawkins,R.E.
  101. Biochim. Biophys. Acta. v.1419 Stabilized plasmid-lipid partcles:factors influencing plasmid entrapment and transfection properties Mok,K.W.C.;Lam,A.M.I.;Cullis,P.R.
  102. Gene Ther. v.7 no.1 Adeno-Associated viruses:is clinical success on the horizon? Monahan,P.E.;Samulski,R.J.
  103. J. Liposoma Res. v.9 no.3 Anti GD2-immunoliposome mediated targeting of 1125-MIBG to neuroblastoma and nelanoma cells in vitro Montaldo,P.G.;Pagnan,G.;Raffaghello,L.;Pastorino,E.;Allen,T.M.;Kirchmeire,M.;Ponzoni,M.
  104. Vaccine v.18 no.20 The immunogenicity of single and combinattion DNA vaccines against tuberculosis Morris,S.;Kelley,C.;Howard,A.;Li,Z.;Collins,E.
  105. Human Gene Ther. v.5 Safety and toxicity of catheter gene delivery to pulmonary vasculature in a patient with metastatic melanoma Nabel,E.G.;Yang,Z.Y.;Muller,D.;Chang,A.E.;Gao,X;Huang,L.;Cho,K.J.;Nabel,G.J.
  106. Crit. Rev. Thera. Drug Carrier Sys. v.12 no.4 Gene introduction in to animal tissue Nakanishi,M.
  107. Ann. Oncol. v.10 no.3 Cytokine gene therapy hopes and pitfalls Nanni,P.;Forni,G.;Lollini,P.L.
  108. Jap. J. Cancer Res. v.91 no.4 Cationic liposome conjugation to recombinant adenoviral vectors reduces viral antigenicity Natsurne,A.;Mizuno,M.;Ryuke,Y.;Yoshida,J.
  109. Cancer Gene Therapy v.5 p53 tumor suppressor gene therapy for cancer Nielsen,L.L.;Maneval,D.C.
  110. FEBS Lett. v.433 no.1-2 Membrane fusion plays an important role in gene transfection mediated by cationic liposomes Noguchi,A.;Furuno,T.;Kawaura,C.;Nakanishi,M.
  111. Gene Ther. v.5 no.10 The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells Ogris,M.;Steinlein,P.;Kursa,M.;Mechtler,K.;Kircheis,R.;Wagner,E.
  112. Int. J. Pharm. v.181 Preparation and evalation of flurbiprofen-loaded microemulsion for parental delivery Park,K.M.;Kim,C.K.
  113. Tumour Targeting v.4 Vactor development for cancer gene therapy Peng,K.W.;Vile,R.
  114. Mol. Med. Today v.5 Strategies for targeting therapeutic gene delivery Peng,K.W.
  115. Trends Cardiovasc Med. v.9 no.6 Systemic gene therapy for cardiovascular disease Ponder,K.P.
  116. Adv. Drug Deliv. Rev. v.34 Key issues in non-viral gene delivery Pouton,C.W.;Seymour,L.W.
  117. Gene transfer and expression of a non viral polycation based vector in CD4+ cells Puls,R.L.;Minchin,R.E.
  118. Mol. Med. Today v.1 Chimeric viral vectors:the best of the both world? Reynold,P.N.;Feng,M.;Cruiel,D.J.
  119. Crit. Rev. Ther. Drug Carrier Sys, v.15 no.2 From genes to gene medicines:recent advances in non-viral gene delivery Rolland,A.P.
  120. Nat. Biotechnol. v.16 no.2 vivo electrically mediated protein and gene transfer in murine melanoma Rols,M.P.;Delteil,C.;Golzio,M.;Dumond,P;Cros,S.;Teissie,J.
  121. Stem Cells v.17 no.4 Gene transfer technology in therapy:current applications and future goals Romano,G.;Pacilio,C.;Giordano,A.
  122. Biochim. Biophys. Acta v.1421 Polyethlene glycol enhances lipoplex-cell association and lipofection Ross,P.C.;Hui,S.W.
  123. J. Liposome Res. v.8 no.4 Multilamellar cationic liposomes are efficient vectors for in vitro gene trasfer in serum Ross,P.C.;Hensen,M.L.;Supabphol,R.;Huis,W.
  124. Gene Therapy. BMJ v.315 no.7118 Science, medicine, and th future Russell,S.J.
  125. J. Controlled Release v.66 Effect of DNA/liposome mixing ratio on the physico-chemical characteristics, cellular uptake and intra-cellular trafficking of plasmid/DNA cationic liposome complexes and the subsequent gene expression Sakurai,F.;Inoue,R.;Nishino,Y.;Okuda,A.;Mastumoto,O.;Taga,T.;Yamashita,F.;Takakura,Y.;Hashida,M.
  126. Gene Ther. v.5 Adenoviral vectors:not to be sneezed at Searle,P.F.;Mautner,V.
  127. Gene Ther. v.7 no.9 A novel N-acyl Phosphatidylethanolamin-containing delivery vehicle for spermine-condensed plasmid DNA Shangguan,T.;Cabral-Lilly,D.;Purandara,U.;Godin,N.;Ahl,P.;Janoff,A.;Meers,P.A.
  128. J. La State. Med. Soc. v.150 no.12 New therpies for cystic fibrosis Simakajornboon,N.;Davis,S.H.
  129. Semin. Oncol. v.2 no.6 Ex vivo gene therapy using cytokine transduced tumor vaccines:molecular and clinical pharmacology Simons,J.W.;Mikha,K.
  130. Biophysica Biochimica Acta v.1375 Ultrastructural characterization of cationic liposome DNA complexs showing enhanced stability in serum and high transfection activity in vivo Sternberg,B.;Hong,K.;Zheng,W.;Papahadjopoulos,D.
  131. FEBS Lett. v.356 New structures in complex formation between DNA and cationic liposomes visualized by freeze fracture electron microscopy Sternberg,B.;Sorgi,F.L.;Huang,L.
  132. J. Endocrinol. v.164 no.2 Viral vectors for gene delivery and gene therapy with in the endocrine system Stone,D.;David,A.;Bolonganani,F.;Lowensterin,P.R.;Castro,M.G.
  133. Cancer Res. v.58 Viral vectors targeted antiangiogenic gene therapy utilizing an angio-statin complementary DNA Tanaka,T.;Cao,Y.;Folkman,J.;Fine,H.A.
  134. Haemophilla v.6 Gene therapy for the haemophilias Thompson,A.R.
  135. J. Controlled Release v.39 Controllable gene therapy:pharmaceutics of non-viral gene delivery systems Tomlinson,E.;Rolland,A.P.
  136. J. Biol. Chem. v.274 no.41 Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression Tseng,W.C.;Haselton,F.R.;Giorgio,T.D.
  137. Mol. Med. Today v.4 Physiologically responsive gene therapy Varley,A.W.;Munford,R.S.
  138. Nature v.389 Gene therapy:promises, problems and prospects Verma,I.;Somia,N.
  139. Gene Ther. v.7 Cancer gene therapy:hard lessions and new courses Vile,R.G.;Russell,S.J.;Lemoine,N.R.
  140. Bioconj. Chem. v.9 Vinogradov,S.V.;Bronich,T.K.;Kabanov,A.V.
  141. Gene Ther. v.5 Transfection of cultured myoblasts in high serum concentration with DODAC:DOPE liposomes Vitiello,L.;Bockhold,K.;Joshi,P.B.;Worton,R.G.
  142. Nature v.392 Germline gene therapy must be spared excessive regulations Wadman,M.
  143. Gastroenterol. v.118 Gene therapy:back to the drawing board Walsh,J.H.
  144. Drug Dev. Rev. v.5 no.1 Adenovirus technology for gene manipulation and functional studies Wang,Y.;Huang,S.
  145. Biophysica Biochimica Acta v.1416 Target cell specificity of fusogenic liposomes:membrane fusion mediated macromolecule delivery in to human blood mononuclear cells Watabe,A.;Yamaghuchi,T.;Kawanishi,T.;Uchida,E.;Eguchi,A.;Mizuguchi,H.;Mayumi,T.;Nakanishi,M.;Hayakawa,T.
  146. Proc. Natl. Acad. Sci. USA v.88 Introduction of foreign genes in to tissues of living mice by DNA coated microprojectiles Williams,R.S.;Johnston,S.A.;Riedy,M.
  147. Hum. Gene. Ther. v.7 no.17 Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers Wolfert,M.A.;Schacht,E.H.;Toncheva,V.;Ulbrich,K.;Nazarova,O.;Seymour,L.W.
  148. Science v.247 Direct gene trasfer in to mouse muscle in vivo Wolff,J.A.;Malone,R.W.;Williams,P.;Chong,W.;Acsadi,G.;Jan,A.;Felgner,P.L.
  149. Curr. Opin. Biotechnol. v.11 Production of viral vectors for gene therapy applications Wu,N.;Attai,M.M.
  150. J. Neurotrauma v.14 Gene therapy for CNS injury:the use of cationic liposomes Yang,K.;Clifton,G.L.;Hayes,R.L.
  151. Nat. Med. v.1 Gene gun and other non-viral approaches for cancer gene therapy Yang,N.S.;Sun,W.H.
  152. Pharm. Res. v.17 no.3 A cationic lipid emulsion/DNA complex as a physically stable and serum-resistant gene delivery system Yi,S.W.;Yune,T.Y.;Kim,T.W.;Chung,H.;Choi,Y.W.;Kwon,I.C.;Lee,E.B.;Jeong,S.Y.
  153. Human Gene Ther. v.11 Intravenous injection of naked DNA encoding fit3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivo Yukai,H.E.;Alexie,A.P.;Nayak,J.V.;Plowey,J.;Falo,Jr.L.D.;Huang,L.
  154. Gene Ther. v.6 Liposome mediated NGF gene transfection following neuronal injury:potential therapeutic injury Zou,L.L.;Huang,L.;Hayes,R.L.;Black,C.;Qiu,Y.H.;Perez-Polo,J.R.;Le,W.;Clifton,G.L.
  155. Intervirology v.42 no.2-3 New antiviral agents for the therapy of chronic hepatitis B virus infection Zoulim,F.;Trepo,C.
  156. Int. J. Pharm. v.183 Characterization of DNA-lipid complexes commonly used for gene delivery Zuidam,N.J.;Barenholz,Y.